The identification and enumeration of tumor cells circulating in the peripheral blood (CTCs) of individuals with metastatic breast cancer has proven to be o
Introduction: HER-2 overexpression, a predictive marker of tumor aggressiveness and responsiveness to therapy,occurs in 20-30% of breast cancer.Although bre